Search Results - "Kekesi, Laszlo"

Signal transduction therapy of cancer with kinase inhibitors by Keri, Gyorgy, Orfi, Laszlo, Greff, Zoltan, Pato, Janos, Szokol, Balint, Kekesi, Laszlo, Sipos, Anna, Garamvolgyi, Rita

Get full text

Design and synthesis of new imidazo[1,2-a]pyridine and imidazo[1,2-a]pyrazine derivatives with antiproliferative activity against melanoma cells by Garamvölgyi, Rita, Dobos, Judit, Sipos, Anna, Boros, Sándor, Illyés, Eszter, Baska, Ferenc, Kékesi, László, Szabadkai, István, Szántai-Kis, Csaba, Kéri, György, Őrfi, László

“…Melanoma is an aggressive form of skin cancer and it is generally associated with poor prognosis in patients with late-stage disease. Due to the increasing…”
Get full text

Lead selection and characterization of antitubercular compounds using the Nested Chemical Library by Sipos, Anna, Pató, János, Székely, Rita, Hartkoorn, Ruben C, Kékesi, László, Őrfi, László, Szántai-Kis, Csaba, Mikušová, Katarína, Svetlíková, Zuzana, Korduláková, Jana, Nagaraja, Valakunja, Godbole, Adwait Anand, Bush, Natassja, Collin, Frédéric, Maxwell, Anthony, Cole, Stewart T, Kéri, György

“…Summary Discovering new drugs to treat tuberculosis more efficiently and to overcome multidrug resistance is a world health priority. To find novel…”
Get full text

Synthesis and biological evaluation of novel pyrido[2,3-b]pyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines by Kékesi, László, Sipos, Anna, Németh, Gábor, Pató, János, Breza, Nóra, Baska, Ferenc, Őrfi, László, Kéri, György

“…A series of novel pyrido[2,3-b]pyrazines were synthesized as potential antitumor agents for erlotinib-resistant tumors. Known signal inhibitor compounds from…”
Get full text

Pyrido[2,3-bpyrazines inhibiting both erlotinib-sensitive and erlotinib-resistant cell lines, and their preparation via regioselective condensation reaction by Kékesi, László, Sipos, Anna, Németh, Gábor, Dancsó, András, Illyés, Eszter, Boros, Sándor, Breza, Nóra, Nemes, Zoltán, Hegymegi-Barakonyi, Bálint, Pató, János, Greff, Zoltán, Kéri, György, Őrfi, László

“…The EGFR inhibitor erlotinib possesses high anti-tumor effect but despite the good clinical responses in most of the cases recrudescence occures. This can be…”
Get more information